FDA approves HIV pre-exposure preventive injection

Pregnant women infected with avian influenza face a 90% maternal and 86% infant mortality rate, underscoring the urgent need for pandemic preparedness and protection strategies.

The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.

A new predictive model, proven reliable and highly accurate, helps identify high-risk patients for postoperative nausea and vomiting, improving outcomes after gynecologic laparoscopic procedures.

A recent study highlights that preoperative anemia significantly increases health care costs and adverse outcomes for patients undergoing elective hysterectomy and myomectomy.